Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Electrochemotherapy in Non-curable Gastric Cancer
NCT04139070Phase 1Unknown
- Sponsor
- Zealand University Hospital
- Start
- Jun 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of bleomycin in gastric cancer (GC), sponsored by Zealand University Hospital. Primary endpoint: Incidence of Treatment-Emergent Adverse Events at 3 months. Status: unknown.
02
Drugs
bleomycin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT04139070.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04139070.